Preparation of buffy coat platelet hyperconcentrates treated with Mirasol® Pathogen Reduction Technology and stored in PAS

被引：0
|
作者：
de Korte, Dirk [1 ]
Marschner, S. [2 ]
Gouwerok, E. [3 ]
Vlaar, R.
Goodrich, R. [4 ]
机构：
[1] Sanquin Blood Bank Reg N W, Amsterdam, Netherlands
[2] Navigant Biotechnol, Lakewood, CO USA
[3] Sanquin Res, Amsterdam, Netherlands
[4] Navigant Biotechnol LLC, Lakewood, CO USA
来源：
TRANSFUSION | 2008年 / 48卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：154A / 154A
页数：1
相关论文
共 50 条
  • [21] EFFECT OF MIRASOL PATHOGEN REDUCTION TECHNOLOGY SYSTEM ON QUALITY OF PLATELETS STORED IN PLASMA
    Llohn, A.
    Skogheim, R.
    Flesland, A.
    Oedegaard, E.
    Mastroianni, M.
    Nybruket, M.
    Nentwich, I
    [J]. VOX SANGUINIS, 2011, 101 : 77 - 77
  • [22] Evaluation of Different Preparation Procedures of Pathogen Reduction Technology(Mirasol®)-Treated Platelets Collected by Plateletpheresis
    Janetzko, Karin
    Hinz, Katharina
    Marschner, Susanne
    Goodrich, Ray
    Klueter, Harald
    [J]. TRANSFUSION MEDICINE AND HEMOTHERAPY, 2009, 36 (05) : 309 - 315
  • [23] BUFFY COAT DERIVED PLATELET CONCENTRATES STORED IN PLASMA, PLASMA-LYTE-A AND PAS-II
    HAWKER, RJ
    MITCHELL, SG
    TURNER, VS
    [J]. TRANSFUSION, 1995, 35 (10) : S36 - S36
  • [24] Evaluation of the quality of Apheresis platelets treated with Mirasol® pathogen reduction technology
    Eakins, E.
    Murphy, C.
    Croxon, H.
    Birhire, R.
    Flynn, N.
    Taylor, S.
    Murphy, W.
    [J]. TRANSFUSION, 2008, 48 (02) : 21A - 21A
  • [25] EVALUATION OF CYTOKINE ACCUMULATION IN MIRASOL® PATHOGEN REDUCTION TECHNOLOGY TREATED PLATELETS
    Castrillo, A.
    Abad, M. L.
    Arcas, C.
    Costoya, S.
    Rodriguez, M., I
    [J]. VOX SANGUINIS, 2010, 99 : 250 - 251
  • [26] The effect of pathogen reduction technology (Mirasol) on platelet quality when treated in additive solution with low plasma carryover
    Johnson, L.
    Winter, K. M.
    Reid, S.
    Hartkopf-Theis, T.
    Marschner, S.
    Goodrich, R. P.
    Marks, D. C.
    [J]. VOX SANGUINIS, 2011, 101 (03) : 208 - 214
  • [27] Platelet Recovery and Survival After Whole Blood Treated with Mirasol Pathogen Reduction
    Hervig, T. A.
    Braathen, H.
    Jaboori, A. A.
    Deberdt, L.
    Bailey, L. S.
    Lunde, T. F.
    [J]. TRANSFUSION, 2016, 56 : 194A - 194A
  • [28] Neutrophil Priming Activity in Platelet Concentrates (PCs) Collected by Apheresis and Treated with Mirasol® Pathogen Reduction Technology (PRT)
    Ambruso, D. R.
    Thurman, G.
    Tran, K.
    Marschner, S.
    Goodrich, R. P.
    [J]. TRANSFUSION, 2009, 49 : 9A - 9A
  • [29] In Vivo Recovery of Platelets Treated with Pathogen Reduction Technology Stored in Platelet Additive Solutions
    Drawz, S. M.
    Marschner, S.
    Yanez, M.
    Garcia de Coca, A.
    Coene, J.
    [J]. TRANSFUSION, 2014, 54 : 40A - 41A
  • [30] Evaluation of platelet mitochondria integrity after treatment with Mirasol pathogen reduction technology
    Li, JZ
    Lockerbie, O
    de Korte, D
    Rice, J
    McLean, R
    Goodrich, RP
    [J]. TRANSFUSION, 2005, 45 (06) : 920 - 926
12345